Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Portable Device Could Test for Physical Property of Tumor Aggressiveness

By LabMedica International staff writers
Posted on 24 May 2015
A new polarimetric fiber stress sensor device has been developed for visco-elastic and biomimetic material analysis, and, as part of the emerging field of physical oncology, is being tested for measuring a tumor’s Young’s modulus—an elasticity-related measure recently linked to cancerous tumor aggressiveness.

Engineers from the Viterbi School of Engineering at the University of Southern California (LA, CA, USA) developed the device and in preliminary testing found that more aggressive tumors are generally stiffer, a complex relationship that requires further study. More...
The device itself is an important step in the challenge of developing non-destructive methods to characterize physical properties of biological materials, and will be suitable for a wide variety of applications. It is an all-fiber-based material analysis device based on optical polarimetry that is different from previous polarimetric systems which rely on free-space components.

"The device leaves the sample completely undamaged, which allows researchers to still perform other tests on it," said Mark Harrison, USC engineering graduate student. Previous detectors required time-consuming alignment and were highly sensitive to environmental vibration. To solve these problems, the new device uses fiber optics, taking a cue from telecommunications. The system adds force onto a sample on top of the optical fiber, changing the polarization of the laser inside in a predictable way that enables calculation of the Young's modulus.

"Instruments able to measure a material's Young's modulus already existed, but they're large and require calibration each time they're moved," said Andrea Armani, USC associate professor of engineering, "Our device could be carried from hospital room to hospital room and doesn't need an engineer to operate it."

Prof. Armani was inspired after a conversation with colleague David Agus, USC professor of medicine and engineering, who told her that Young’s modulus has been linked to tumor aggressiveness but he lacked an easy-to-use device for testing that metric. "This advancement from Prof. Armani is so exciting, as we now have a new dimension of a tumor to measure. We are studying the role of Young's modulus together with Prof. Armani to help personalize and improve a cancer patient's care," said Prof. Agus.

In addition to evaluating the device's role in a clinical setting, there is also increased interest on a more fundamental level: understanding how different types of tumors are related to their mechanical properties. Emphasis has mostly been placed on the chemical makeup of tumors so most current tests to probe the nature of cancerous tumors focus on chemical makeup—an important feature to understand, but only part of whole the picture. "Physical oncology represents a completely fresh approach to tackling the problem of cancer. It has the potential to provide huge insights as scientists throughout the world try to understand, treat, and ultimately prevent cancer in humans," said Peter Kuhn, USC professor who helped launch a new peer-reviewed journal on physical oncology.

"Given how safe, stable, and accurate this instrument is, it could play a pivotal role in both diagnostic and research efforts," said Prof. Armani. The team next will work with Prof. Agus to test it in a clinical setting. They also hope to create a more sensitive version of the device that can map Young’s modulus across tumors.

The study, by Harrison MC and Armani AM, was published online May 14, 2015, in the journal Applied Physics Letters.

Related Links:
University of Southern California 

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.